Dr. Paul Auwaerter discusses therapeutics, vaccines, and more about emerging variants of COVID-19. Topics: * Changes to NIH recommendations for mild to moderate COVID-19 * New monoclonal antibody: bebtelovimab  * Monoclonal antibody evasion in omicron sublineages * Revisions to booster dose schedules for immunocompromised people  


Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/2-16-22-episode/eval

Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty 


Presenting faculty:  

Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine 


See acast.com/privacy for privacy and opt-out information.